Handelsbanken Fonder’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$270M Sell
538,524
-96,304
-15% -$46.2M 0.77% 19
2026
Q1
$312M Sell
634,828
-80,700
-11% -$43.8M 1.04% 13
2025
Q4
$415M Buy
715,528
+12,390
+2% +$7.01M 1.25% 11
2025
Q3
$341M Buy
703,138
+202,017
+40% +$94M 1.08% 13
2025
Q2
$203M Buy
501,121
+107,590
+27% +$45M 0.72% 19
2025
Q1
$196M Buy
393,531
+19,311
+5% +$10.5M 0.81% 18
2024
Q4
$195M Sell
374,220
-18,761
-5% -$10.3M 0.74% 20
2024
Q3
$243M Buy
392,981
+2,320
+0.6% +$1.37M 0.96% 14
2024
Q2
$216M Sell
390,661
-20,745
-5% -$11.9M 0.94% 13
2024
Q1
$239M Buy
411,406
+5,831
+1% +$3.27M 1.03% 13
2023
Q4
$215M Buy
405,575
+51,464
+15% +$24.9M 1.05% 13
2023
Q3
$179M Sell
354,111
-24,036
-6% -$12.8M 1% 13
2023
Q2
$197M Sell
378,147
-89,860
-19% -$48.5M 1.06% 10
2023
Q1
$270M Buy
468,007
+27,615
+6% +$15.6M 1.56% 7
2022
Q4
$243M Sell
440,392
-704
-0.2% -$373K 1.52% 6
2022
Q3
$224M Buy
441,096
+16,898
+4% +$9.46M 1.5% 8
2022
Q2
$230M Buy
424,198
+37,928
+10% +$20.9M 1.5% 8
2022
Q1
$228M Sell
386,270
-1,699
-0.4% -$976K 1.27% 11
2021
Q4
$259M Buy
387,969
+16,451
+4% +$10.3M 1.27% 10
2021
Q3
$212M Sell
371,518
-23,329
-6% -$12.8M 1.11% 13
2021
Q2
$199M Sell
394,847
-13,768
-3% -$6.5M 1.04% 14
2021
Q1
$186M Buy
408,615
+10,130
+3% +$4.84M 1.06% 13
2020
Q4
$186M Buy
398,485
+1,881
+0.5% +$882K 1.13% 9
2020
Q3
$175M Buy
396,604
+3,362
+0.9% +$1.39M 1.28% 7
2020
Q2
$142M Buy
393,242
+56,999
+17% +$19.1M 1.19% 11
2020
Q1
$95.4M Sell
336,243
-18,070
-5% -$5.7M 2.05% 9
2019
Q4
$115M Buy
354,313
+3,270
+0.9% +$992K 1.99% 10
2019
Q3
$102M Buy
351,043
+5,325
+2% +$1.52M 2.07% 8
2019
Q2
$102M Sell
345,718
-15,661
-4% -$4.31M 1.88% 11
2019
Q1
$98.9M Sell
361,379
-5,975
-2% -$1.49M 1.92% 8
2018
Q4
$82.2M Buy
367,354
+14,789
+4% +$3.47M 1.66% 16
2018
Q3
$86.1M Buy
352,565
+45,200
+15% +$10.4M 1.62% 13
2018
Q2
$63.7M Buy
307,365
+143,800
+88% +$30.5M 1.25% 18
2018
Q1
$33.8M Buy
163,565
+45,800
+39% +$9.61M 0.66% 54
2017
Q4
$22.4M Buy
117,765
+300
+0.3% +$57.5K 0.49% 62
2017
Q3
$22.2M Sell
117,465
-1,000
-0.8% -$181K 0.51% 59
2017
Q2
$20.7M Buy
118,465
+17,500
+17% +$2.94M 0.53% 60
2017
Q1
$15.5M Buy
100,965
+5,000
+5% +$764K 0.43% 74
2016
Q4
$13.5M Sell
95,965
-15,000
-14% -$2.21M 0.41% 76
2016
Q3
$17.6M Sell
110,965
-1,887
-2% -$291K 0.52% 74
2016
Q2
$16.7M Sell
112,852
-5,000
-4% -$738K 0.68% 60
2016
Q1
$16.7M Sell
117,852
-59,887
-34% -$8.03M 0.71% 57
2015
Q4
$25.2M Buy
+177,739
New +$23.7M 0.49% 61

Other funds holding TMO

Handelsbanken Fonder's TMO Position: Q2 2026 in Review

Handelsbanken Fonder reduced its Thermo Fisher Scientific (TMO) stake by 15% in Q2 2026, selling an estimated $46.2M and leaving 538,524 shares worth $270M. The position accounts for 0.77% of the portfolio, ranked #19.

Handelsbanken Fonder first reported a position in TMO in Q4 2015 and has held it in 43 quarters since. The position peaked at $415M in Q4 2025. 1,201 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Handelsbanken Fonder held 538,524 shares of Thermo Fisher Scientific worth $270M as of Q2 2026.
  • Handelsbanken Fonder sold 96,304 Thermo Fisher Scientific shares in Q2 2026, an estimated $46.2M.
  • Thermo Fisher Scientific made up 0.77% of Handelsbanken Fonder's portfolio in Q2 2026, its #19 holding.
  • Handelsbanken Fonder first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 43 quarters since.
  • Handelsbanken Fonder's Thermo Fisher Scientific position peaked at $415M in Q4 2025.
  • 1,201 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.